In Vivo CAR-T Double Knockout Screen Identifies Synergistic Antitumor Gene Pairs

The supplied material is a bibliography for research on engineered immune-cell therapies, with a focus on chimeric antigen receptor (CAR) T cells, T-cell exhaustion, CRISPR-based screening and genome engineering. The references also cover tumor immunology, cellular metabolism, gene regulation, single-cell analysis, sequencing and computational methods used to study and improve these therapies.

References

1. Li, Y.-R., Zhu, Y., Halladay, T. & Yang, L. “In vivo CAR engineering for immunotherapy.” Nature Reviews Immunology 25, 725–744 (2025). Article · PubMed
2. Zebley, C. C. & Youngblood, B. “Mechanisms of T cell exhaustion guiding next-generation immunotherapy.” Trends in Cancer 8, 726–734 (2022). Article · PubMed · PubMed Central
3. Kirchhammer, N., Trefny, M. P., Auf der Maur, P., Läubli, H. & Zippelius, A. “Combination cancer immunotherapies: emerging treatment strategies adapted to the tumor microenvironment.” Science Translational Medicine 14, eabo3605 (2022). Article · PubMed
4. Patel, U. et al. “CAR T cell therapy in solid tumors: a review of current clinical trials.” eJHaem 3, 24–31 (2022). Article · PubMed
5. Wei, J. et al. “Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy.” Nature 576, 471–476 (2019). Article · PubMed
6. Carnevale, J. et al. “RASA2 ablation in T cells boosts antigen sensitivity and long-term function.” Nature 609, 174–182 (2022). Article · PubMed
7. Freitas, K. A. et al. “Enhanced T cell effector activity by targeting the Mediator kinase module.” Science 378, eabn5647 (2022). Article · PubMed
8. Arce, M. M. et al. “Central control of dynamic gene circuits governs T cell rest and activation.” Nature 637, 930–939 (2025). Article · PubMed
9. Agarwal, S. et al. “Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells.” Immunity 56, 2388–2407.e9 (2023). Article · PubMed
10. Rowshanravan, B., Halliday, N. & Sansom, D. M. “CTLA-4: a moving target in immunotherapy.” Blood 131, 58–67 (2018). Article · PubMed
11. Sharpe, A. H. & Pauken, K. E. “The diverse functions of the PD1 inhibitory pathway.” Nature Reviews Immunology 18, 153–167 (2018). Article · PubMed
12. Sitaram, P., Uyemura, B., Malarkannan, S. & Riese, M. J. “Beyond the cell surface: targeting intracellular negative regulators to enhance T cell anti-tumor activity.” International Journal of Molecular Sciences 20, 5821 (2019). Article · PubMed
13. Liu, X. et al. “Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction.” Nature 567, 525–529 (2019). Article · PubMed
14. Chen, J. et al. “NR4A transcription factors limit CAR T cell function in solid tumours.” Nature 567, 530–534 (2019). Article · PubMed
15. Seo, H. et al. “TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8⁺ T cell exhaustion.” Proceedings of the National Academy of Sciences USA 116, 12410–12415 (2019). Article · PubMed
16. Henriksson, J. et al. “Genome-wide CRISPR screens in T helper cells reveal pervasive crosstalk between activation and differentiation.” Cell 176, 882–896.e18 (2019). Article · PubMed
17. Shifrut, E. et al. “Genome-wide CRISPR screens in primary human T cells reveal key regulators of immune function.” Cell 175, 1958–1971.e15 (2018). Article · PubMed
18. Shi, H., Doench, J. G. & Chi, H. “CRISPR screens for functional interrogation of immunity.” Nature Reviews Immunology 23, 363–380 (2023). Article · PubMed
19. Zhou, L., Yang, L., Feng, Y. & Chen, S. “Pooled screening with next-generation gene editing tools.” Current Opinion in Biomedical Engineering 28, 100479 (2023). Article
20. Zhou, X., Renauer, P. A., Zhou, L., Fang, S.-Y. & Chen, S. “Applications of CRISPR technology in cellular immunotherapy.” Immunological Reviews 320, 199–216 (2023). Article
21. Dong, M. B. et al. “Systematic immunotherapy target discovery using genome-scale in vivo CRISPR screens in CD8 T cells.” Cell 178, 1189–1204.e23 (2019). Article
22. Ye, L. et al. “In vivo CRISPR screening in CD8 T cells with AAV–Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastoma.” Nature Biotechnology 37, 1302–1313 (2019). Article
23. Dai, X. et al. “Massively parallel knock-in engineering of human T cells.” Nature Biotechnology 41, 1239–1255 (2023). Article
24. Chen, Z. et al. “In vivo CD8⁺ T cell CRISPR screening reveals control by Fli1 in infection and cancer.” Cell 184, 1262–1280.e22 (2021). Article
25. Huang, H. et al. “In vivo CRISPR screening reveals nutrient signaling processes underpinning CD8⁺ T cell fate decisions.” Cell 184, 1245–1261.e21 (2021). Article
26. Fu, G. et al. “Metabolic control of TFH cells and humoral immunity by phosphatidylethanolamine.” Nature 595, 724–729 (2021). Article
27. Guo, A. et al. “cBAF complex components and MYC cooperate early in CD8⁺ T cell fate.” Nature 607, 135–141 (2022). Article
28. Shen, J. P. et al. “Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions.” Nature Methods 14, 573–576 (2017). Article
29. Chow, R. D. et al. “In vivo profiling of metastatic double knockouts through CRISPR-Cpf1 screens.” Nature Methods 16, 405–408 (2019). Article
30. Campa, C. C., Weisbach, N. R., Santinha, A. J., Incarnato, D. & Platt, R. J. “Multiplexed genome engineering by Cas12a and CRISPR arrays encoded on single transcripts.” Nature Methods 16, 887–893 (2019). Article
31. Li, R. et al. “Comparative optimization of combinatorial CRISPR screens.” Nature Communications 13, 2469 (2022). Article
32. Tang, S. et al. “Generation of dual-gRNA library for combinatorial CRISPR screening of synthetic lethal gene pairs.” STAR Protocols 3, 101556 (2022). Article
33. Prinzing, B. et al. “Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity.” Science Translational Medicine 13, eabh0272 (2021). Article
34. LaFleur, M. W. et al. “PTPN2 regulates the generation of exhausted CD8⁺ T cell subpopulations and restrains tumor immunity.” Nature Immunology 20, 1335–1347 (2019). Article
35. Aki, D. et al. “The E3 ligases Itch and WWP2 cooperate to limit T_H2 differentiation by enhancing signaling through the TCR.” Nature Immunology 19, 766–775 (2018). Article
36. Nurieva, R. I. et al. “The E3 ubiquitin ligase GRAIL regulates T cell tolerance and regulatory T cell function by mediating T cell receptor-CD3 degradation.” Immunity 32, 670–680 (2010). Article
37. Huang, C.-Y. et al. “DUSP4 deficiency enhances CD25 expression and CD4⁺ T-cell proliferation without impeding T-cell development.” European Journal of Immunology 42, 476–488 (2012). Article
38. Dashevsky, O. et al. “Use of olfactory receptor genes as controls for genome-scale CRISPR functional genomic studies to define treatment resistance mechanisms.” Blood 136, 36 (2020). Article
39. Zhao, D. et al. “Combinatorial CRISPR-Cas9 metabolic screens reveal critical redox control points dependent on the KEAP1-NRF2 regulatory axis.” Molecular Cell 69, 699–708.e7 (2018). Article
40. Yang, L. et al. “OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours.” Nature 652, 740–751 (2026). Article
41. Rosskopf, S. et al. “A Jurkat 76 based triple parameter reporter system to evaluate TCR functions and adoptive T cell strategies.” Oncotarget 9, 17608–17619 (2018). Article
42. Ye, L. et al. “A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy.” Cell Metabolism 34, 595–614.e14 (2022). Article
43. Mise-Omata, S. et al. “SOCS3 deletion in effector T cells confers an anti-tumorigenic role of IL-6 to the pro-tumorigenic cytokine.” Cell Reports 42, 112940 (2023). Article
44. Negishi, S. et al. “Treatment strategies for relapse after CAR T-cell therapy in B cell lymphoma.” Frontiers in Pediatrics 11, 1305657 (2023). Article
45. Liberzon, A. et al. “The Molecular Signatures Database (MSigDB) hallmark gene set collection.” Cell Systems 1, 417–425 (2015). Article
46. Shi, H., Chen, S. & Chi, H. “Immunometabolism of CD8⁺ T cell differentiation in cancer.” Trends in Cancer 10, 610–626 (2024). Article
47. Dumauthioz, N. et al. “Enforced PGC-1α expression promotes CD8 T cell fitness, memory formation and antitumor immunity.” Cellular & Molecular Immunology 18, 1761–1771 (2021). Article
48. Andreatta, M. et al. “Interpretation of T cell states from single-cell transcriptomics data using reference atlases.” Nature Communications 12, 2965 (2021). Article
49. Liu, Y. et al. “Chimeric STAR receptors using TCR machinery mediate robust responses against solid tumors.” Science Translational Medicine 13, eabb5191 (2021). Article
50. Nelson, R. “FDA investigating safety risks in CAR T-cell recipients.” The Lancet 402, 2181 (2023). Article
51. Ashburner, M. et al. “Gene Ontology: tool for the unification of biology.” Nature Genetics 25, 25–29 (2000). Article
52. The Gene Ontology Consortium. “The Gene Ontology knowledgebase in 2023.” Genetics 224, iyad031 (2023). Article
53. Schmiedel, B. J. et al. “Impact of genetic polymorphisms on human immune cell gene expression.” Cell 175, 1701–1715.e16 (2018). Article
54. Joung, J. et al. “Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening.” Nature Protocols 12, 828–863 (2017). Article
55. Martin, M. “Cutadapt removes adapter sequences from high-throughput sequencing reads.” EMBnet.journal (2011). Article
56. Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. “Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.” Genome Biology 10, R25 (2009). Article
57. Li, X., Cooper, N. G. F., O’Toole, T. E. & Rouchka, E. C. “Choice of library size normalization and statistical methods for differential gene expression analysis in balanced two-group comparisons for RNA-seq studies.” BMC Genomics 21, 75 (2020). Article
58. Lun, A. T. L., Chen, Y. & Smyth, G. K. “It’s DE-licious: a recipe for differential expression analyses of RNA-seq experiments using quasi-likelihood methods in edgeR.” Methods in Molecular Biology 1418, 391–416 (2016). Article
59. Ritchie, M. E. et al. “limma powers differential expression analyses for RNA-sequencing and microarray studies.” Nucleic Acids Research 43, e47 (2015). Article
60. Clement, K. et al. “CRISPResso2 provides accurate and rapid genome editing sequence analysis.” Nature Biotechnology 37, 224–226 (2019). Article
61. Roederer, M., Nozzi, J. L. & Nason, M. C. “SPICE: exploration and analysis of post-cytometric complex multivariate datasets.” Cytometry A 79, 167–174 (2011). Article
62. Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. “Near-optimal probabilistic RNA-seq quantification.” Nature Biotechnology 34, 525–527 (2016). Article
63. Frankish, A. et al. “Gencode 2021.” Nucleic Acids Research 49, D916–D923 (2021). Article
64. Hao, Y. et al. “Dictionary learning for integrative, multimodal and scalable single-cell analysis.” Nature Biotechnology (2023). Article
65. Welch, J. D. et al. “Single-cell multi-omic integration compares and contrasts features of brain cell identity.” Cell 177, 1873–1887.e17 (2019). Article
66. Trapnell, C. et al. “The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells.” Nature Biotechnology 32, 381–386 (2014). Article
67. Aibar, S. et al. “SCENIC: single-cell regulatory network inference and clustering.” Nature Methods 14, 1083–1086 (2017). Article
68. Andrews, S. “FastQC: a quality control tool for high throughput sequence data.” GitHub (2010).
69. Langmead, B. & Salzberg, S. L. “Fast gapped-read alignment with Bowtie 2.” Nature Methods 9, 357–359 (2012). Article
70. Danecek, P. et al. “Twelve years of SAMtools and BCFtools.” GigaScience 10, giab008 (2021). Article
71. Quinlan, A. R. & Hall, I. M. “BEDTools: a flexible suite of utilities for comparing genomic features.” Bioinformatics 26, 841–842 (2010). Article
72. Amemiya, H. M., Kundaje, A. & Boyle, A. P. “The ENCODE Blacklist: identification of problematic regions of the genome.” Scientific Reports 9, 9354 (2019). Article
73. Zhang, Y. et al. “Model-based analysis of ChIP-seq (MACS).” Genome Biology 9, R137 (2008). Article
74. Heinz, S. et al. “Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities.” Molecular Cell 38, 576–589 (2010). Article
75. Ramirez, F. et al. “deepTools2: a next generation web server for deep-sequencing data analysis.” Nucleic Acids Research 44, W160–W165 (2016). Article
76. Li, H. & Durbin, R. “Fast and accurate short read alignment with Burrows-Wheeler transform.” Bioinformatics 25, 1754–1760 (2009). Article
77. McKenna, A. et al. “The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.” Genome Research 20, 1297–1303 (2010). Article
78. Cameron, D. L. et al. “GRIDSS: sensitive and specific genomic rearrangement detection using positional de Bruijn graph assembly.” Genome Research 27, 2050–2060 (2017). Article
79. Zhang, H., Meltzer, P. & Davis, S. “RCircos: an R package for Circos 2D track plots.” BMC Bioinformatics 14, 244 (2013). Article

Source: www.nature.com